This inventor holds 1 USPTO granted patent. Top assignee: National Cancer Center. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Dae Seok Kim: Innovator in Cancer Treatment
Introduction
Dae Seok Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on enhancing the effectiveness of chemotherapy while minimizing side effects for patients.
Latest Patents
Dae Seok Kim holds a patent for a cancer sensitizer comprising glucosamine, glucosamine derivatives, or salts thereof. This patent, which is designed to sensitize cancer cells to anticancer agents, has the potential to improve therapeutic efficiency in chemotherapy without producing adverse side effects. The patent is a testament to his commitment to advancing cancer treatment.
Career Highlights
Dae Seok Kim is affiliated with the National Cancer Center, where he conducts research aimed at improving cancer therapies. His work has garnered attention for its innovative approach to sensitizing cancer cells, which could lead to better outcomes for patients undergoing chemotherapy.
Collaborations
Dae Seok Kim collaborates with fellow researcher Soo Youl Kim, contributing to the advancement of cancer treatment methodologies. Their combined efforts aim to push the boundaries of current cancer therapies and improve patient care.
Conclusion
Dae Seok Kim's contributions to cancer treatment through his innovative patent and research at the National Cancer Center highlight his dedication to improving patient outcomes. His work represents a significant step forward in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile